Cargando…
Management of Emotional Dysregulation in Adult ADHD
INTRODUCTION: Attention-Deficit/Hyperactivity Disorder (ADHD) is characterized by impairing symptoms of inattention and/or hyperactivity/impulsivity. Although Emotional Dysregulation (ED) is not current criteria for ADHD, several clinical, imaging and genetic studies have been suggesting its inclusi...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9568011/ http://dx.doi.org/10.1192/j.eurpsy.2022.1858 |
_version_ | 1784809542452772864 |
---|---|
author | Tavares, F. Viseu, M. Barbosa Pinto, M. Solana, C. |
author_facet | Tavares, F. Viseu, M. Barbosa Pinto, M. Solana, C. |
author_sort | Tavares, F. |
collection | PubMed |
description | INTRODUCTION: Attention-Deficit/Hyperactivity Disorder (ADHD) is characterized by impairing symptoms of inattention and/or hyperactivity/impulsivity. Although Emotional Dysregulation (ED) is not current criteria for ADHD, several clinical, imaging and genetic studies have been suggesting its inclusion. ED seems to impair social and occupational capacities, leading to poor quality life. In this regard, managing this situation is fundamental. OBJECTIVES: ED in ADHD review and its management, including pharmacological and nonpharmacological approaches. METHODS: Non-systematic review through literature using databases as Pubmed and UpToDate. Keywords used: Attention-Deficit/Hyperactivity Disorder, Emotional Dysregulation, management, pharmacotherapy. RESULTS: Literature refers to ADHD drugs, such as psychostimulants and atomoxetine, as the first line managing ED. However, some studies demonstrated that ADHD drugs have lower efficacy while treating emotional symptoms, when compared to attention or hyperactivity/impulsivity symptom control. Other medications, such as antidepressants or mood stabilizers, are not considered due to low efficacy and side effects (such as irritability or suicidality behaviour worsening). Regarding non pharmacological approaches, there have been results with cognitive behavioral treatment, and management techniques for anger, frustration and communication skills. CONCLUSIONS: Although the majority of studies demonstrate psychostimulants and atomoxetine role, there is an important lack of information regarding management of ADHD emotional dysregulation. It is a multifactorial condition, and, as such, non pharmacological and pharmacological management are needed to address this issue. More research is necessary, in order to improve patients’ quality of life. DISCLOSURE: No significant relationships. |
format | Online Article Text |
id | pubmed-9568011 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Cambridge University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-95680112022-10-17 Management of Emotional Dysregulation in Adult ADHD Tavares, F. Viseu, M. Barbosa Pinto, M. Solana, C. Eur Psychiatry Abstract INTRODUCTION: Attention-Deficit/Hyperactivity Disorder (ADHD) is characterized by impairing symptoms of inattention and/or hyperactivity/impulsivity. Although Emotional Dysregulation (ED) is not current criteria for ADHD, several clinical, imaging and genetic studies have been suggesting its inclusion. ED seems to impair social and occupational capacities, leading to poor quality life. In this regard, managing this situation is fundamental. OBJECTIVES: ED in ADHD review and its management, including pharmacological and nonpharmacological approaches. METHODS: Non-systematic review through literature using databases as Pubmed and UpToDate. Keywords used: Attention-Deficit/Hyperactivity Disorder, Emotional Dysregulation, management, pharmacotherapy. RESULTS: Literature refers to ADHD drugs, such as psychostimulants and atomoxetine, as the first line managing ED. However, some studies demonstrated that ADHD drugs have lower efficacy while treating emotional symptoms, when compared to attention or hyperactivity/impulsivity symptom control. Other medications, such as antidepressants or mood stabilizers, are not considered due to low efficacy and side effects (such as irritability or suicidality behaviour worsening). Regarding non pharmacological approaches, there have been results with cognitive behavioral treatment, and management techniques for anger, frustration and communication skills. CONCLUSIONS: Although the majority of studies demonstrate psychostimulants and atomoxetine role, there is an important lack of information regarding management of ADHD emotional dysregulation. It is a multifactorial condition, and, as such, non pharmacological and pharmacological management are needed to address this issue. More research is necessary, in order to improve patients’ quality of life. DISCLOSURE: No significant relationships. Cambridge University Press 2022-09-01 /pmc/articles/PMC9568011/ http://dx.doi.org/10.1192/j.eurpsy.2022.1858 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Abstract Tavares, F. Viseu, M. Barbosa Pinto, M. Solana, C. Management of Emotional Dysregulation in Adult ADHD |
title | Management of Emotional Dysregulation in Adult ADHD |
title_full | Management of Emotional Dysregulation in Adult ADHD |
title_fullStr | Management of Emotional Dysregulation in Adult ADHD |
title_full_unstemmed | Management of Emotional Dysregulation in Adult ADHD |
title_short | Management of Emotional Dysregulation in Adult ADHD |
title_sort | management of emotional dysregulation in adult adhd |
topic | Abstract |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9568011/ http://dx.doi.org/10.1192/j.eurpsy.2022.1858 |
work_keys_str_mv | AT tavaresf managementofemotionaldysregulationinadultadhd AT viseum managementofemotionaldysregulationinadultadhd AT barbosapintom managementofemotionaldysregulationinadultadhd AT solanac managementofemotionaldysregulationinadultadhd |